These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 11918531)

  • 1. Effect of fluconazole prophylaxis on fungal blood cultures: an autopsy-based study involving 720 patients with haematological malignancy.
    Kami M; Machida U; Okuzumi K; Matsumura T; Mori Si S; Hori A; Kashima T; Kanda Y; Takaue Y; Sakamaki H; Hirai H; Yoneyama A; Mutou Y
    Br J Haematol; 2002 Apr; 117(1):40-6. PubMed ID: 11918531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis of invasive fungal infections: advances in nonculture systems.
    Walsh TJ; Chanock SJ
    Curr Clin Top Infect Dis; 1998; 18():101-53. PubMed ID: 9779353
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical features and treatment of invasive fungal infection in 47 patients with hematological malignancies].
    Zhu Y; Chen SP; Shu YG; Xu YJ
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Jan; 33(1):89-92. PubMed ID: 18245913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies. U.K. Multicentre Antifungal Prophylaxis Study Group.
    Morgenstern GR; Prentice AG; Prentice HG; Ropner JE; Schey SA; Warnock DW
    Br J Haematol; 1999 Jun; 105(4):901-11. PubMed ID: 10554799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia.
    Glasmacher A; Cornely O; Ullmann AJ; Wedding U; Bodenstein H; Wandt H; Boewer C; Pasold R; Wolf HH; Hänel M; Dölken G; Junghanss C; Andreesen R; Bertz H;
    J Antimicrob Chemother; 2006 Feb; 57(2):317-25. PubMed ID: 16339606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluconazole prophylaxis against fungal colonization and infection in preterm infants.
    Kaufman D; Boyle R; Hazen KC; Patrie JT; Robinson M; Donowitz LG
    N Engl J Med; 2001 Dec; 345(23):1660-6. PubMed ID: 11759644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary antifungal prophylaxis with micafungin in patients with haematological malignancies: real-life data from a retrospective single-centre observational study.
    Nachbaur D; Angelova O; Orth-Höller D; Ditlbacher A; Lackner M; Auberger J; Lass-Flörl C
    Eur J Haematol; 2015 Mar; 94(3):258-64. PubMed ID: 25082655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In meta-analysis itraconazole is superior to fluconazole for prophylaxis of systemic fungal infection in the treatment of haematological malignancy.
    Prentice AG; Glasmacher A; Djulbegovic B
    Br J Haematol; 2006 Mar; 132(5):656-8; author reply 658-9. PubMed ID: 16445845
    [No Abstract]   [Full Text] [Related]  

  • 9. PCR-restriction enzyme analysis for detection of Candida DNA in blood from febrile patients with hematological malignancies.
    Morace G; Pagano L; Sanguinetti M; Posteraro B; Mele L; Equitani F; D'Amore G; Leone G; Fadda G
    J Clin Microbiol; 1999 Jun; 37(6):1871-5. PubMed ID: 10325339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro antifungal spectrum of itraconazole and treatment of systemic mycoses with old and new antimycotic agents.
    Van Cutsem J
    Chemotherapy; 1992; 38 Suppl 1():3-11. PubMed ID: 1319313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fungal infections in marrow transplant recipients under antifungal prophylaxis with fluconazole.
    Oliveira JS; Kerbauy FR; Colombo AL; Bahia DM; Pinheiro GS; Silva MR; Ribeiro MS; Raineri G; Kerbauy J
    Braz J Med Biol Res; 2002 Jul; 35(7):789-98. PubMed ID: 12131918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Systemic mycotic infections].
    Meunier F
    Recenti Prog Med; 1990 Jan; 81(1):18-22. PubMed ID: 2173078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Current aspects of medical mycology].
    Dupouy-Camet J; Bougnoux ME; Ancelle T
    Ann Biol Clin (Paris); 1989; 47(2):102-7. PubMed ID: 2660634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hema e-Chart registry of invasive fungal infections in haematological patients: improved outcome in recent years in mould infections.
    Nosari AM; Caira M; Pioltelli ML; Fanci R; Bonini A; Cattaneo C; Castagnola C; Capalbo SF; De Fabritiis P; Mettivier V; Morselli M; Pastore D; Aversa F; Rossi G; Pagano L;
    Clin Microbiol Infect; 2013 Aug; 19(8):757-62. PubMed ID: 23279327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fungal infections in the immunocompromised host.
    Stein DK; Sugar AM
    Diagn Microbiol Infect Dis; 1989; 12(4 Suppl):221S-228S. PubMed ID: 2686923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surveillance of triazole susceptibility of colonizing yeasts in patients with haematological malignancies.
    Chryssanthou E; Cherif H; Petrini B; Kalin M; Björkholm M
    Scand J Infect Dis; 2004; 36(11-12):855-9. PubMed ID: 15764173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Common invasive fungal diseases: an overview of invasive candidiasis, aspergillosis, cryptococcosis, and Pneumocystis pneumonia.
    Schmiedel Y; Zimmerli S
    Swiss Med Wkly; 2016; 146():w14281. PubMed ID: 26901377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Weekly use of fluconazole as prophylaxis in haematological patients at risk for invasive candidiasis.
    Vuichard D; Weisser M; Orasch C; Frei R; Heim D; Passweg JR; Widmer AF
    BMC Infect Dis; 2014 Nov; 14():573. PubMed ID: 25384689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of fluconazole prophylaxis on fungal colonization and infection rates in neutropenic patients. The Canadian Fluconazole Study.
    Laverdière M; Rotstein C; Bow EJ; Roberts RS; Ioannou S; Carr D; Moghaddam N
    J Antimicrob Chemother; 2000 Dec; 46(6):1001-8. PubMed ID: 11102422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.